Cyclin D1 protein expression and gene polymorphism in colorectal cancer

International Journal of Cancer

Volumn 88, Issue 1, 2000, Pages 77-81

  McKay, Judith A ^a   Douglas, Joy J ^a   Ross, Val G ^b   Curran, Stephanie ^b   Murray, Graeme I ^b   Cassidy, Jim ^a   McLeod, Howard L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; DNA POLYMORPHISM; EXON; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; CYCLIN D1; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; SUBCELLULAR FRACTIONS; SURVIVAL ANALYSIS;

EID: 0033859008     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O     Document Type: Article

References (30)

1. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
2. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas
3. Cyclin D1 protein expression and function in human breast cancer
4. Management of survival of patients with adenocarcinoma of the colon and rectum: A national survey of the Commission on Cancer
5. Alternate splicing produces a novel cyclin D1 transcript
6. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer
7. Expression and amplification of cyclin genes in human breast cancer
8. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
9. The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
10. Glycogen synthase kinase-3b regulates cyclin D1 proteolysis and subcellular localization
11. Cyclin D1 and prognosis in human breast cancer
12. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
13. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer
14. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas
15. Cyclin D1 expression is regulated positively by the p42/p44(MAPK) and negatively by the p38/HOG(MAPK) pathway
16. Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma
17. Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry
18. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck
19. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases
20. Tumor markers of prognosis in colorectal cancer
21. Principles of CDK regulation
22. Expression of cyclin D1 and retinoblastoma protein in colorectal cancer
23. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner
24. Role of the retinoblastoma protein in the pathogenesis of human cancer
25. Reciprocal Rb inactivation and p16(INK4) expression in primary lung cancers and cell lines
26. Cancer cell cycles
27. The cyclin D1 gene is a target of the b-catenin/LEF-1 pathway
28. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
29. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis
30. 1 phase